Channing Robertson | |
---|---|
Channing Rex Robertson | |
Born | 1943or1944(age 79–80) [1] |
Nationality | American |
Education | Herbert Hoover High School |
Alma mater | University of California, Berkeley Stanford University |
Years active | 1961-present |
Board member of | Theranos |
Spouse | Donna Reineke Robertson |
Scientific career | |
Fields | Chemical engineering |
Institutions | Stanford University Theranos |
Academic advisors | Andreas Acrivos |
Doctoral students | Seth Darst |
Other notable students | Elizabeth Holmes |
Website | engineering |
Channing Rex Robertson is a professor emeritus of chemical engineering at Stanford University. He held multiple significant roles at startup Theranos, founded by his student Elizabeth Holmes. Robertson took on major responsibilities at the company prior to its collapse, including becoming its first board member, engaging with venture capitalists, and recruiting biochemist Ian Gibbons. He retired from Stanford in 2012, becoming professor emeritus. Theranos named him the co-leader of their technology advisory board in 2017. He was called as a witness in United States v. Elizabeth A. Holmes, et al. , which convicted Holmes and partner Sunny Balwani of criminal fraud. During his time working for Holmes, Robertson was paid US$500,000 per year by Theranos. Since his active role in the Theranos scandal, he went back to teach one course at Stanford.
Robertson spent the early part of his life in Los Angeles, California. [2] He went to Herbert Hoover High School in Glendale, California, where he met his wife, Donna Reineke. [3] [4] Reineke graduated from Hoover in 1960, with Robertson following in 1961. [4] He received a Bachelor of Science degree in chemical engineering from the University of California at Berkeley, [5] followed by a Master of Science in chemical engineering at Stanford University, where his focus included transport phenomena and fluid mechanics. [5] Robertson received his Doctor of Philosophy (Ph. D) from Stanford under the supervision of Andreas Acrivos. [6] [7] After graduating from Stanford with his Ph. D, Robertson left academia to become a researcher for in the oil industry; later returning to Stanford to work in the field of bioengineering. [2] Reineke became director of donor relations at Stanford in 1990. She retired from the institution in 2020. [3]
Robertson joined the Stanford faculty in 1970. [7] He served as the Ruth G. and William K. Bowes Professor and Senior Associate Dean for Faculty & Academic Affairs in the School of Engineering. [5] He was an advisor to doctoral student Seth Darst. [8] Robertson testified in 1998 as a witness for the state about the cigarette brand Marlboro related to a lawsuit against tobacco company Philip Morris USA. [9] In 2000, he was featured in a special issue of Upside , entitled "100 People Who Have Changed the World". [5] He was a founding fellow of the American Institute for Medical and Biological Engineering. [5] After the collapse of Theranos, Robertson returned to Stanford as professor emeritus, teaching the course "Busting Energy Myths". [7] [10]
Robertson taught Theranos founder Elizabeth Holmes when she was a student at Stanford. [11] [12] He became acquainted with her after granting her request to work in a research laboratory at Stanford amidst Ph. D graduate students. [13] Robertson was initially swayed by his student's ideas on what she felt her fledgling technology could accomplish. [14] [15] After Holmes dropped out, Robertson helped her start Theranos in 2003. [16] He went on to become the company's first board member. [17] [18] [19] Robertson gave up his academic tenure teaching position in order to work at Theranos. [20] Along with Robertson, his associate from his lab Shaunak Roy also joined Holmes at Theranos and became its co-founder. [16] [21] [22] Shaunak and Holmes had previously worked together in Robertson's lab at Stanford. [23] Robertson brought venture capitalists to meet with Holmes about her early business venture. [24] [25] He convinced Ian Gibbons to work for Theranos in 2005. [7] [26] [27] Robertson and Gibbons had previously worked together in the 1980s and co-authored a patent at Biotrack Laboratories. [28] [29] Gibbons brought confidential concerns about Theranos to Robertson in confidence, including the fact that the technology was not working. [26] [30] Gibbons asked Robertson to keep his private comments about Theranos between them. [26] Robertson then immediately shared Gibbons's concerns with Holmes, who fired Gibbons. [31] [26]
Holmes kept a quote from Robertson featured on her desk: "You start to realize you are looking in the eyes of another Bill Gates, or Steve Jobs." [32] After receiving this assessment from Robertson, Holmes later began to dress like Jobs. [33] Robertson was included in activities related to Holmes's personal life, and was a featured guest at her 30th birthday party at the home of fellow Theranos board member and former United States Secretary of State George Shultz. [34]
According to criminal filings by prosecutors in United States v. Elizabeth A. Holmes, et al. , Robertson was paid approximately US$463,000 by Theranos from March 2015 to February 2016. [35] In 2017, Theranos named him the co-leader of their technology advisory board. [36] [37] [38] Brian Grossman of PFM Health Sciences relied upon expertise by Robertson, prior to his firm's investment in Theranos. [39] Grossman spoke directly with Robertson, before deciding to invest $96 million in Theranos. [39] [40] According to The Verge , PFM Health Sciences chief investment officer Brian Grossman testified that he met with Robertson prior to his firm investing US$96 million in Theranos. [39] Robertson assured him Theranos's technology was sound and years ahead of competitors. [39] Robertson stated to Grossman that the only risk related to the company was with customer experiences. [39] After speaking with Robertson, Grossman felt confident in his firm's investment in Theranos. [39] Grossman testified under oath as to his conversation with Robertson about Theranos, in the U.S. government's criminal trial against Holmes. [41] Robertson kept what was happening at Theranos secret, and did not tell his wife what was happening at the company. [42]
Following a report by Wall Street Journal investigative journalist John Carreyrou on questionable medical practices at Theranos, Robertson defended the company in an interview with Bloomberg Businessweek . [43] [44] Robertson told Bloomberg Businessweek, "We would have to be certifiable", to go live with actual medical patients with a product that impacted individuals' health, with foreknowledge the tests were not dependable. [43] [44] In the same interview, Robertson classed Holmes among geniuses including Leonardo da Vinci, Wolfgang Amadeus Mozart, Albert Einstein, and Isaac Newton. [43] [44]
As late as May 2018, Robertson believed the company was successful in developing novel blood testing technology. [45] According to lawyer Reed Kathrein, who sued Theranos on behalf of some of its former investors, the company only paid Robertson to lend itself credibility. [45] Robertson maintained ties to Theranos, continuing to both work at the company and serve on its board of directors until 2018. [46] Kathrein said Holmes, "compensated him very, very well. From 2013 through 2017 she paid him more than anyone else at the company. ... From what I can tell, she paid him $500,000 a year for those four years." [45] Robertson confirmed his income in testimony during litigation between Theranos and Richard Fuisz. [47] Kathrein described Robertson as the person in the world who "would have known the right questions to ask". [45] Robertson was a witness in U.S. v. Holmes, at the conclusion of which Holmes and partner Sunny Balwani were convicted of criminal fraud. [7]
The Wall Street Journal investigative journalist John Carreyrou delved into the manner in which Elizabeth Holmes courted Robertson to involve himself in her company Theranos; he recounted this in-depth in his 2018 book, Bad Blood: Secrets and Lies in a Silicon Valley Startup . [48] [49] [50] This relationship was investigated further in the 2019 Alex Gibney documentary, The Inventor: Out for Blood in Silicon Valley . [51] [52] [53] Rebecca Jarvis delved into the early background between Robertson and Holmes, in her 2019 podcast about Theranos, The Dropout . [54] [55] [56] In the 2022 American biographical television drama miniseries The Dropout , based on the Jarvis podcast of the same name, Robertson was portrayed by actor Bill Irwin. [57] [25]
David Boies is an American lawyer and chairman of the law firm Boies Schiller Flexner LLP. Boies rose to national prominence for three major cases: leading the U.S. federal government's successful prosecution of Microsoft in United States v. Microsoft Corp., his unsuccessful representation of Democratic presidential candidate Al Gore in Bush v. Gore, and for successful representation of the plaintiff in Hollingsworth v. Perry, which invalidated California Proposition 8 banning same-sex marriage. Boies has also represented various clients in US lawsuits, including Theranos, tobacco companies, Harvey Weinstein, and Jeffrey Epstein's victims including Virginia Roberts Giuffre.
Stephen T. Jurvetson is an American billionaire businessman and venture capitalist. Formerly a partner of the firm Draper Fisher Jurvetson (DFJ), he was an early investor in Hotmail, Memphis Meats, Mythic and Nervana Systems. He is currently a board member of SpaceX among others. He later co-founded the firm Future Ventures with Maryanna Saenko, who worked with him at DFJ.
Timothy Cook Draper is an American venture capital investor, and founder of Draper Fisher Jurvetson (DFJ), Draper University, Draper Venture Network, and Draper Associates. Since 2019, he is a partner in Draper Goren Holm. His most prominent investments include Baidu, Hotmail, Skype, Tesla, SpaceX, AngelList, SolarCity, Ring, Twitter, DocuSign, Coinbase, Robinhood, Ancestry.com, Twitch, Cruise Automation, PrettyLitter and Focus Media. In July 2014, Draper received wide coverage for his purchase at a US Marshals Service auction of seized bitcoins from the Silk Road website. Draper is a proponent of Bitcoin and decentralization. Draper was also one of the first investors in Theranos.
Charles Louis Fleischmann was a Jewish Hungarian-American manufacturer of yeast who founded Fleischmann Yeast Company.
Boies Schiller Flexner LLP is an American law firm based in New York City. The firm was founded by David Boies and Jonathan D. Schiller, in 1997, who, in 1999, were joined by Donald L. Flexner, former partner with Crowell & Moring, then forming Boies, Schiller & Flexner.
Wade Miquelon is an American business executive and former CEO of Jo-Ann Stores. He was previously an executive at Procter & Gamble and Walgreens.
Theranos Inc. was an American privately held corporation that was touted as a breakthrough health technology company. Founded in 2003 by then 19-year-old Elizabeth Holmes, Theranos raised more than US$700 million from venture capitalists and private investors, resulting in a $10 billion valuation at its peak in 2013 and 2014. The company claimed that it had devised blood tests that required very small amounts of blood and that could be performed rapidly and accurately, all using compact automated devices that the company had developed. These claims were proven to be false.
Elizabeth Anne Holmes is an American biotechnology entrepreneur who was convicted of fraud in connection to her blood-testing company, Theranos. The company's valuation soared after it claimed to have revolutionized blood testing by developing methods that needed only very small volumes of blood, such as from a fingerprick. In 2015, Forbes had named Holmes the youngest and wealthiest self-made female billionaire in the United States on the basis of a $9-billion valuation of her company. In the following year, as revelations of fraud about Theranos's claims began to surface, Forbes revised its estimate of Holmes's net worth to zero, and Fortune named her in its feature article on "The World's 19 Most Disappointing Leaders".
Noble cause corruption is corruption caused by the adherence to a teleological ethical system, suggesting that people will use unethical or illegal means to attain desirable goals, a result which appears to benefit the greater good. Where traditional corruption is defined by personal gain, noble cause corruption forms when someone is convinced of their righteousness, and will do anything within their powers to achieve the desired result. An example of noble cause corruption is police misconduct "committed in the name of good ends" or neglect of due process through "a moral commitment to make the world a safer place to live." The knowing misconduct by a law enforcement officer or prosecutor with the goal of attaining what the officer believes is a "just" result.
Joseph Fuisz is an American attorney, inventor, and entrepreneur of Slovenian descent. He works predominantly in the pharmaceutical industry as the founder of Fuisz Pharma LLC. As of October 2015, he is named on 32 medical patents, and over forty patents.
John Carreyrou is a French-American investigative reporter at The New York Times. Carreyrou worked for The Wall Street Journal for 20 years between 1999 and 2019 and has been based in Brussels, Paris, and New York City. He won the Pulitzer Prize twice and is well known for having exposed the fraudulent practices of the multibillion-dollar blood-testing company Theranos in a series of articles published in The Wall Street Journal.
Ramesh "Sunny" Balwani is a businessman, former president and chief operating officer of Theranos, which was a privately held health technology company founded by his then-girlfriend Elizabeth Holmes. He and Holmes fraudulently represented that they had devised a revolutionary blood test that required only small amounts of blood, such as from a fingerstick. Both Balwani and Holmes were convicted of fraud. The consequences of the fraud led to the collapse of Theranos and the loss of billions of dollars to investors.
Bad Blood: Secrets and Lies in a Silicon Valley Startup is a nonfiction book by journalist John Carreyrou, released May 21, 2018. It covers the rise and fall of Theranos, the multibillion-dollar biotech startup headed by Elizabeth Holmes. The book received critical acclaim, winning the 2018 Financial Times and McKinsey Business Book of the Year Award.
Ian Gibbons was a British biochemist and molecular biology researcher who served as the chief scientist of the US company Theranos, which was founded by Elizabeth Holmes. For more than 30 years, Gibbons performed research in medical therapeutics and diagnostic testing prior to joining Theranos in 2005. He attempted to raise issues with Theranos' management about the inaccuracy of their testing devices.
The Inventor: Out for Blood in Silicon Valley is a 2019 American documentary film, directed and produced by Alex Gibney. The film revolves around Elizabeth Holmes and her former company Theranos. It is considered a companion piece to the book, Bad Blood: Secrets and Lies in a Silicon Valley Startup.
Roger Harris Parloff is an American journalist who formerly worked at Fortune and currently is a senior editor at Lawfare.
The Dropout is an American biographical drama television miniseries that dramatises the rise and fall of the disgraced biotechnology company Theranos and its founder, Elizabeth Holmes, played by Amanda Seyfried. It features an ensemble supporting cast, including Naveen Andrews, Elizabeth Marvel, William H. Macy, Stephen Fry, Mary Lynn Rajskub, Bill Irwin, Utkarsh Ambudkar, LisaGay Hamilton, Michael Ironside, Laurie Metcalf, Anne Archer, and Sam Waterston. Created by Elizabeth Meriwether, the series is based on the podcast of the same name hosted by Rebecca Jarvis and produced by ABC News.
Phyllis I. Gardner is a Professor of Medicine at the Stanford University School of Medicine, and former Dean of Education. Gardner was one of the first people to be publicly skeptical of Elizabeth Holmes, the founder of blood testing company Theranos, who was later found guilty of investor fraud.
The Dropout is an American true crime podcast hosted by Rebecca Jarvis that follows the story of Elizabeth Holmes, her defunct medical company Theranos, and the related federal criminal fraud trial, United States v. Elizabeth A. Holmes, et al. It was produced by ABC News, Taylor Dunn, Victoria Thompson, and Rebecca Jarvis. After the initial six episodes of the podcast aired in 2019, a two-hour 20/20 episode premiered in March 2019, following the popularity of the podcast. A second season of the podcast, titled, The Dropout: Elizabeth Holmes on Trial, debuted in 2022 and followed along with the criminal fraud federal trial of Holmes.
United States v. Elizabeth A. Holmes, et al., was a United States federal criminal fraud case against the founder of now-defunct corporation Theranos, Elizabeth Holmes, and its former president and COO, Ramesh Balwani. The case alleged that Holmes and Balwani perpetrated multi-million dollar wire-fraud schemes against investors and patients. Holmes and Balwani each had their own jury trial.
{{cite web}}
: CS1 maint: location (link)